Cigna Corp (CI) 126.50 $CI Cigna Assists People Affected

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cigna Corp (CI) 126.50 $CI

Cigna Assists People Affected by Orlando Shooting With 24x7 Telephone Help Line
BusinessWire - 1 hr 50 mins ago
Cigna (NYSE: CI) is expanding access to its 24x7 telephone help line to provide personal assistance and support for anyone affected by the tragic shooting in Orlando. Phone lines are staffed with qualified clinicians who are available to speak with people about how to cope with loss, anxiety, stress, fear or other issues related to gun violence.
CI: 126.50 (-1.58)

Travel costs for kidney donors to be reimbursed by insurer
By TOM MURPHY - AP - Sun Jun 12, 9:01AM CDT
Travel costs that could dissuade potential kidney donors from volunteering for life-saving transplants will be reimbursed by the nation's biggest insurer starting next year in a move designed to encourage more donations.
CI: 126.50 (-1.58), UNH: 138.09 (-1.15), AET: 119.18 (-1.34)

Cigna Global Health Benefits appoints Neil Irwin as Head of Global Distribution
BusinessWire - Fri Jun 10, 8:00AM CDT
Cigna Global Health Benefits(R) (NYSE: CI) today announced the appointment of Neil Irwin as Head of Global Distribution. In this role, Neil will be responsible for cross-market growth and development of Cigna's globally mobile group health business across multiple client and customer segments around the globe.
CI: 126.50 (-1.58)

UnitedHealth (UNH) Hikes Dividend by 25%, Stock Climbs
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 10:13AM CDT
UnitedHealth (UNH) has once again cheered its investors by instituting a quarterly dividend hike of 25%.
CI: 126.50 (-1.58), UNH: 138.09 (-1.15), AET: 119.18 (-1.34), HUM: 184.69 (-2.07)

Cigna Launches New Company to Deliver Proven Systems, Capabilities and Management Services to More Health Care Providers
BusinessWire - Thu Jun 09, 8:00AM CDT
--Will enable health care provider success under a variety of value-based and risk-sharing models
CI: 126.50 (-1.58)

CIGNA Rises 1.65% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 08, 2:24PM CDT
CIGNA (NYSE:CI) traded in a range yesterday that spanned from a low of $128.44 to a high of $131.40. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $131.25 on volume of 388,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CI: 126.50 (-1.58)

After Yesterday's Rally of 1.65% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 08, 2:23PM CDT
CIGNA (NYSE:CI) traded in a range yesterday that spanned from a low of $128.44 to a high of $131.40. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $131.25 on volume of 388,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CI: 126.50 (-1.58)

UnitedHealth Hits 52-Week High as it Recalibrates Business
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:33AM CDT
UnitedHealth (UNH) 52-week high was propelled by continued strength in the company's earnings and its recent exit from a number of exchanges.
CI: 126.50 (-1.58), ANTM: 130.68 (-0.84), UNH: 138.09 (-1.15), AET: 119.18 (-1.34), HUM: 184.69 (-2.07)

UnitedHealth Exits California State Exchange to Check Losses
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:10AM CDT
UnitedHealth Group Inc. (UNH) is calling it quits in the public exchange business in California, which is one of the key markets.
CI: 126.50 (-1.58), UNH: 138.09 (-1.15), AET: 119.18 (-1.34), HUM: 184.69 (-2.07)

The Zacks Analyst Blog Highlights: Torchmark, Argo Group International Holdings, Cigna and Horace Mann Educators
Zacks Equity Research - Zacks Investment Research - Fri May 27, 8:30AM CDT
The Zacks Analyst Blog Highlights: Torchmark, Argo Group International Holdings, Cigna and Horace Mann Educators
CI: 126.50 (-1.58), AGII: 52.59 (-0.93), TMK: 59.89 (-0.29), HMN: 32.89 (-0.51)

4 Insurance Stocks to Buy Before a Rate Hike
Zacks Equity Research - Zacks Investment Research - Thu May 26, 10:51AM CDT
We don't know if the Federal Open Market Committee will make any positive change to the interest rate at its Jun 15 meeting. We have picked four solid insurers that have the potential to boost one's portfolio irrespective of a rate hike.
AGII: 52.59 (-0.93), CI: 126.50 (-1.58), TMK: 59.89 (-0.29), HMN: 32.89 (-0.51)

Anthem Receives Approval for Cigna Acquisition from Indiana Department of Insurance
BusinessWire - Thu May 26, 7:30AM CDT
Anthem, Inc. (NYSE: ANTM) announced today it has received the Final Order from Indiana Department of Insurance Commissioner Stephen W. Robertson, approving the company's acquisition of Cigna HealthCare of Indiana, Inc., a wholly owned subsidiary of Cigna Corporation (NYSE:CI). On July 23, 2015 Anthem and Cigna entered into a definitive agreement whereby Anthem will acquire all outstanding shares of Cigna in a cash-and-stock transaction. The transaction continues to achieve key milestones and, with the recent action in Indiana, has now obtained regulatory clearance in 12 states.
CI: 126.50 (-1.58), ANTM: 130.68 (-0.84)

Florida insurers request rate hikes under federal health law
By KELLI KENNEDY - AP - Wed May 25, 8:15PM CDT
FORT LAUDERDALE, Fla. (AP) — Nearly a dozen health insurers are proposing rate increases averaging 13 percent for 2017 Florida plans sold on the exchanges created under President Barack Obama's health care law, according to federal officials, but that won't necessarily mean big consumer price hikes.
CI: 126.50 (-1.58), AET: 119.18 (-1.34)

Cigna Survey: U.S. Workers Rely on Good Intentions More Than Disability Coverage to Protect Financial Health
BusinessWire - Wed May 25, 8:00AM CDT
--About two out of five American workers worry about unexpected medical costs
CI: 126.50 (-1.58)

How are These Health Care Stocks Faring? - Cigna, Molina Healthcare, Humana, and WellCare Health Plans
PR Newswire - Wed May 25, 7:20AM CDT
The challenge of affordability continues to impact the Health Care Plans industry, but despite this, the space continues to hold some note-worthy companies. Today, ActiveWallSt.com looks at four equities in this segment to evaluate their recent technical performances: Cigna Corp. (NYSE: CI), Molina Healthcare Inc. (NYSE: MOH), Humana Inc. (NYSE: HUM), and WellCare Health Plans Inc. (NYSE: WCG). Register with us to have access to our free technical alerts:
CI: 126.50 (-1.58), WCG: 103.23 (-1.01), MOH: 50.49 (-0.24), HUM: 184.69 (-2.07)

Monsanto gains on offer from Bayer; Tribune plunges
AP - Mon May 23, 3:33PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday:
CI: 126.50 (-1.58), ANTM: 130.68 (-0.84), TPUB: 13.04 (-0.01), ARCC: 14.26 (-0.23), MON: 107.05 (-2.15), CF: 28.62 (-0.61), ANTX: 44.54 (+0.04), TLRD: 11.39 (-0.21)

SmarTrend Watching for Potential Rebound in Shares of CIGNA After 4.00% Loss
Comtex SmarTrend(R) - Mon May 23, 12:04PM CDT
CIGNA (NYSE:CI) traded in a range yesterday that spanned from a low of $125.63 to a high of $128.50. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $127.20 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CI: 126.50 (-1.58)

Look for Shares of CIGNA to Potentially Rebound after Yesterday's 4.00% Sell Off
Comtex SmarTrend(R) - Mon May 23, 12:02PM CDT
CIGNA (NYSE:CI) traded in a range yesterday that spanned from a low of $125.63 to a high of $128.50. Yesterday, the shares fell 4.0%, which took the trading range below the 3-day low of $127.20 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CI: 126.50 (-1.58)

Cigna Outlines Steps to Help Curb National Drug Epidemic
BusinessWire - Thu May 19, 7:05AM CDT
--Treats substance use disorder as a chronic disease
CI: 126.50 (-1.58)

Newell Brands Appoints Ralph Nicoletti Chief Financial Officer
BusinessWire - Fri May 13, 7:00AM CDT
Newell Brands Inc. (NYSE: NWL) announced today that the company has appointed Ralph Nicoletti Executive Vice President and Chief Financial Officer, effective June 8, 2016. The announcement follows the recent combination of Newell Rubbermaid and Jarden Corporation, which closed on April 15, 2016, forming a new $16 billion consumer goods powerhouse.
CI: 126.50 (-1.58), NWL: 47.73 (-0.22), TIF: 61.02 (-0.75)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 87

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 119

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 177

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 38

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 104

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 198

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading

Top 5 Most Recently Viewed Articles

MiMedx Group Q4 Earnings: Impressive Beat Raises Eyebrows

Updated Category News Views 262

What a Turnaround! Numbers don’t lie, right? Well, take a look at MiMedx Group (NASDAQ:MDXG) and you see a company that’s done some real transformation. Their Q4 report came out on February 25, 2026, and it’s hard not to be impressed. They smashed the earnings estimate—by a whopping 40%. That’s no small feat in this market, especially when you look at the EPS...

Continue Reading
Intuitive Machines Sets Financial Results Conference Call Date

Updated Category News Views 132

Intuitive Machines Schedules Conference Call for Financial Results Intuitive Machines, Inc. (Nasdaq: LUNR) has made an important announcement regarding its upcoming financial results. The company is set to release its fourth quarter and full-year financial outcomes, providing an in-depth look at its performance for 2024. This announcement will be made on a specific date...

Continue Reading
OSB Group PLC: Insights into the Latest Block Listing Return

Updated Category News Views 326

Understanding OSB Group PLC's Block Listing Return In the ever-evolving landscape of financial markets, regular disclosures play a pivotal role in maintaining transparency. Here, we delve into the latest block listing return from OSB Group PLC, outlining crucial details in a clear and concise manner. Key Details of the Block Listing Return It's essential for stakeholders...

Continue Reading
Gemini Expands its Offerings with Tokenized U.S. Equities

Updated Category News Views 342

Gemini Launches Tokenized U.S. Equities In an exciting development for European investors, Gemini has expanded its offerings by facilitating the trading of tokenized U.S. equities. This marks a significant shift in providing easier access to international investment opportunities. Initially launched for its user base in Europe, Gemini aims to create a seamless experience...

Continue Reading
Vivian Health Welcomes New CEO Bill Kong for Future Growth

Updated Category News Views 125

Vivian Health's New Era with CEO Bill Kong Vivian Health, a prominent player in the healthcare jobs marketplace, is transitioning into a new chapter under the leadership of Bill Kong, who has been appointed as the CEO. This strategic move follows the remarkable success achieved by Parth Bhakta, co-founder and outgoing CEO, who now assumes the role of Executive Chairman....

Continue Reading